Lu, Yu-ChengYu-ChengLuCHAO-YUAN HUANGYU-CHUAN LUKUO-HOW HUANGPO-MING CHOWYI-KAI CHANGHung, Fan-ChingFan-ChingHungCHUNG-HSIN CHENFU-SHAN JAWJIAN-HUA HONG2021-01-292021-01-292021-010929-6646https://scholars.lib.ntu.edu.tw/handle/123456789/543812In advanced or high-grade prostate cancer (PCa), prostate-specific antigen (PSA) is usually elevated, however, some patients may present with low initial PSA (iPSA) levels. The objective of this study was to evaluate whether different iPSA levels were associated with dissimilar clinical outcomes among men with high-grade PCa and advanced disease after robot-assisted laparoscopic radical prostatectomy (RaLRP).Initial prostate-specific antigen; Prostate cancer; Radical prostatectomy[SDGs]SDG3prostate specific antigen; prostate specific antigen; adult; advanced cancer; aged; Article; biochemical recurrence; cancer grading; cancer growth; controlled study; follow up; Gleason score; hazard ratio; human; laparoscopic surgery; log rank test; major clinical study; male; progression free survival; prostate cancer; robot-assisted prostatectomy; surgical margin; disease exacerbation; prostate tumor; prostatectomy; tumor recurrence; Disease Progression; Humans; Male; Neoplasm Grading; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasmsjournal article10.1016/j.jfma.2020.06.021325911572-s2.0-85086726054https://scholars.lib.ntu.edu.tw/handle/123456789/542056